The FDA will mandate its strictest safety warning on Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy, ...
Coave Therapeutics has announced its lead gene therapy program, CoTx-10, for the treatment of retinal vascular diseases, such ...
Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to ...
WYFF News 4 on MSN
Greer, South Carolina, family hosts fundraiser for gene therapy to treat children with rare disorder
A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...
In medicine these days, the word "gene" shows up in all sorts of different contexts and conjugations. There's genetics, of course, and there's genomics. Then there's meta-genomics -- and don't forget ...
Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, ...
The US FDA has tightened the use of a Duchenne muscular dystrophy gene therapy after two teenage patients died from acute ...
Sharonville, Ohio, celebrates the opening of the new Cincinnati Children's Applied Gene and Cell Therapy Center.
A rare disease that has cut off children from the outside world now potentially has a cure. A clinical trial to treat severe ...
Risk of “acute, serious, and life-threatening” heart inflammation is now on the label of Sarepta's gene therapy for Duchenne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback